MRI monitoring of Avastin™ antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MRI monitoring of Avastin™ antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer

Published:2004-10-22 Issue:5 Volume:20 Page:865-873
ISSN:1053-1807
Container-title:Journal of Magnetic Resonance Imaging
language:en
Short-container-title:J. Magn. Reson. Imaging

Author:

Preda Anda,Novikov Viktor,Möglich Martina,Turetschek Karl,Shames David M.,Brasch Robert C.,Cavagna Friedrich M.,Roberts Timothy P.L.

Funder

Whitaker Foundation

Bracco S.p.A.

Drie Lichten Foundation

Johan Vermeij Foundation

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Radiology Nuclear Medicine and imaging

Reference47 articles.

1. Molecular mechanisms of developmental and tumor angiogenesis;Plate;Brain Pathol,1994

2. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis;Hanahan;Cell,1996

3. Regulators of angiogenesis;Klagsbrun;Annu Rev Physiol,1991

4. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer;Brown;Hum Pathol,1995

5. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis;Warren;J Clin Invest,1995

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcumin incorporated titanium dioxide nanoparticles as MRI contrasting agent for early diagnosis of atherosclerosis- rat model;Veterinary and Animal Science;2020-12

2. Conspicuity of prostate cancer on multiparametric magnetic resonance imaging: A cross‐disciplinary translational hypothesis;The FASEB Journal;2020-09-13

3. Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers;Chemical Reviews;2018-10-16

4. Dynamic Contrast-enhanced Magnetic Resonance Imaging for Patients with Breast Cancer Receiving First-line Bevacizumab and Paclitaxel;Anticancer Research;2018-09

5. Theranostics and contrast agents for magnetic resonance imaging;Biomaterials Research;2018-07-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3